IDIDFC MFRegular · Growth

Bandhan BSE Healthcare Index Fund - Regular Plan - Growth

Index Funds - OtherIndex Funds - OtherBenchmark: BSE Health Care - TRI
NAV · 15 Sep 2026₹11.47-1.49%
AUM₹21 Cr
Expense Ratio1.13%
1Y CAGR+12.12%
Exit Load0.25% on or before 15D, Nil after 15D
Min SIP₹100
Launched2024

Investment Objective

The investment objective of the Scheme is to replicate the BSE Healthcare Index by investing in securities of the BSE Healthcare Index in the same proportion / weightage with an aim to provide returns before expenses that track the total return of BSE Healthcare Index, subject to tracking errors.

Fund Mandate

Debt & Money Market instruments0%–5%
Securities belonging to the Bandhan BSE Healthcare Index (including stock and index derivatives)95%–100%
Asset Allocation
Domestic Equity100.1%
Fund Managers
AJ
Abhishek Jain
Fund Manager
Key Information
1.13%
₹100
₹1,000
0.25% on or before 15D, Nil after 15D
Nil
Inception06 Sep 2024
AMCIDFC MF
Top Holdings
1Sun Pharmaceutical Industries LimitedPharmaceuticals & Biotechnology12.95%
2Divi's Laboratories LimitedPharmaceuticals & Biotechnology7.22%
3Apollo Hospitals Enterprise LimitedHealthcare Services5.55%
4Cipla LimitedPharmaceuticals & Biotechnology4.91%
5Max Healthcare Institute LimitedHealthcare Services4.62%
6Laurus Labs LimitedPharmaceuticals & Biotechnology4.48%
7Torrent Pharmaceuticals LimitedPharmaceuticals & Biotechnology4.36%
8Dr. Reddy's Laboratories LimitedPharmaceuticals & Biotechnology4.35%
9Lupin LimitedPharmaceuticals & Biotechnology3.24%
10Fortis Healthcare LimitedHealthcare Services2.90%
Sector Allocation
Pharmaceuticals & Biotechnology58.1%
Healthcare Services14.3%
Trailing Returns
PeriodReturnsCategory avg
1 Day-1.49%
1 Week-2.20%
1 Month-1.08%
3 Months+6.95%
6 Months+17.64%
9 Months+14.31%
1 Year+12.12%+0.43%
2 Years+6.07%
+7.01%

Category avg is the average return of every scheme in this fund's SEBI class (Index Funds - Other) over the same period. Returns up to 1 year are absolute; returns beyond 1 year are annualised (CAGR). This is Accord's own stated convention for equity-oriented schemes.

Risk Metrics
13.12%

A measure of how much a fund's returns swing up and down over time. Higher means a bumpier ride — more volatility — even if the average return ends up the same as a steadier fund.

0.63

How sensitive a fund is to overall market moves. A beta of 1 means it roughly moves in line with the market; below 1 means smaller swings than the market; above 1 means bigger swings in both directions.

-0.37

How much extra return a fund earned for every unit of risk (volatility) it took on, compared to a safe, risk-free investment. Higher means better risk-adjusted performance — not just higher returns, but smarter ones.

-0.17%

The extra return a fund generated above what its benchmark index would predict, given the risk it took. Positive alpha suggests the fund manager added genuine value beyond just tracking the market.

-0.65

Similar to the Sharpe Ratio, but only counts downside volatility (the bad kind) rather than penalizing a fund for volatile-but-positive swings. Higher means better returns per unit of "harmful" risk.

-9.86%

The single worst peak-to-trough fall a fund has experienced over a given period — the deepest "how much would I have lost if I'd bought at the top and sold at the bottom" scenario.

Fees
1.13%
0.25% on or before 15D, Nil after 15D
Nil
₹100
₹1,000
Capital Gains Tax, general rules

This is an equity-oriented fund. Under rules effective since Budget 2024 (23 July 2024):

Short-Term Capital Gains (held ≤ 12 months): taxed at a flat 20%.

Long-Term Capital Gains (held > 12 months): taxed at 12.5% on gains above ₹1.25 lakh in a financial year, with no indexation benefit.

General information only, not tax advice, actual liability depends on your overall income and applicable law at the time of redemption. Consult a tax advisor for your specific situation.

Frequently Asked QuestionsGeneral mutual-fund FAQs, not specific to this scheme